
Retired Fort Worth Police Chief Neil Noakes Joins The American Warrior Association as Chief of Strategic Advancement, Marks A New Chapter for Moral Injury Advocacy and First Responder Wellness
FORT WORTH, Texas--(BUSINESS WIRE)--Just weeks after Texas lawmakers stood alongside The American Warrior Association (AWA) in support of their program R3: Respond, Restore, Resolve – and first responders – to officially proclaim May 14, 2025, as Moral Injury Awareness Day, retired Fort Worth Police Department (FWPD) Chief Neil Noakes has joined the AWA as its Chief of Strategic Advancement, bringing decades of frontline experience and nationally respected leadership in public safety and officer wellness to advance the R3 program.
'I know the toll this work can take on first responders and their families. When I retired from the FWPD, I hoped to continue serving the community and the profession that's given so much to me. I'm grateful the AWA is the next step,' commented Noakes.
Share
'I know the toll this work can take on first responders and their families. When I retired from the FWPD, I hoped to continue serving the community and the profession that's given so much to me. I'm grateful the AWA is the next step,' commented Noakes. 'The R3 program is providing critically important awareness of first responder wellness and the effects of moral injury, while simultaneously breaking the stigma surrounding mental health in the first responder community. I'm so proud and thankful to be part of the R3 team.'
Chief Noakes brings unmatched perspective to his new role. The son of a firefighter and 25 years of his own service with the FWPD, he has a unique understanding of pressures faced by first responders. During his tenure as Chief, he led several wellness-focused initiatives, including the launch of the department's Wellness Unit and the implementation of the Checkpoint system—a tool designed to monitor and support officer wellness. Noakes was instrumental in launching the inaugural R3 program with both FWPD and FWFD, the first partnership of its kind to recognize the urgency of addressing moral injury.
'Chief Noakes represents the heart of what AWA stands for—service, integrity, and action. His firsthand experience and deep commitment to first responder wellness make him an extraordinary addition to our team,' said AWA Executive Director Anna Heil. 'He's not just joining an organization; he's joining a movement to change how we care for those who serve. We are incredibly grateful to have his leadership as we expand the reach and impact of R3.'
Noakes' professional credentials include:
Master's Degree in Criminal Justice and Criminology from Texas Christian University (TCU)
Bachelor's Degree in Criminal Justice Administration from Tarleton State University
Associate's Degree from Weatherford College
Graduate of TCU's inaugural Leadership, Executive and Administrative Development (LEAD) Program, where he now serves as a cofounder and instructor
Graduate of the Southern Police Institute's 137th Administrative Officers Course, a nationally recognized law enforcement leadership program
During the 89 th Legislative Session, the Texas House and Senate presented official Resolutions establishing the first ever Moral Injury Awareness Day in Texas. The bipartisan effort underscores the state's commitment to raising awareness of the psychological and emotional toll faced by military members, veterans, first responders, frontline professionals and their families. Moral injury, a condition distinct from PTSD, and often considered its precursor, occurs when individuals witness, participate in, or fail to prevent actions that violate their moral values, leading to guilt, shame and moral distress.
About R3 – Respond, Restore, Resolve
Launched in Fort Worth and powered by the American Warrior Association (AWA), R3 is a pioneering initiative that equips first responders with the tools, support and resources needed to proactively address moral injury and improve mental, emotional, and spiritual well-being. The program enhances resilience, reduces absenteeism, and builds healthier departments—ultimately improving service to the community.
R3 programming has been adopted by the Fort Worth and Dallas Fire and Police Departments, as well as DFW International Airport, with growing interest from multiple agencies across the state. Earlier this year, the Texas Tactical Police Officers Association (TTPOA) became an R3 Partner. The TTPOA membership base is approximately 5,500 individuals working within 2,300 organizations.
About the American Warrior Association
The American Warrior Association (AWA) is a Texas-based 501(c)(3) nonprofit organization dedicated to supporting our nation's military, veterans, first responders, and their families in mind, body, and soul. As the national steward of the R3 initiative, AWA continues to lead the charge in addressing the long-term wellness of America's frontline professionals.
For more information about the R3 initiative, visit: https://www.awa-usa.org/programs/r3-program.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
6 days ago
- Yahoo
Retired Fort Worth Police Chief Neil Noakes Joins The American Warrior Association as Chief of Strategic Advancement, Marks A New Chapter for Moral Injury Advocacy and First Responder Wellness
FORT WORTH, Texas, June 23, 2025--(BUSINESS WIRE)--Just weeks after Texas lawmakers stood alongside The American Warrior Association (AWA) in support of their program R3: Respond, Restore, Resolve – and first responders – to officially proclaim May 14, 2025, as Moral Injury Awareness Day, retired Fort Worth Police Department (FWPD) Chief Neil Noakes has joined the AWA as its Chief of Strategic Advancement, bringing decades of frontline experience and nationally respected leadership in public safety and officer wellness to advance the R3 program. "I know the toll this work can take on first responders and their families. When I retired from the FWPD, I hoped to continue serving the community and the profession that's given so much to me. I'm grateful the AWA is the next step," commented Noakes. "The R3 program is providing critically important awareness of first responder wellness and the effects of moral injury, while simultaneously breaking the stigma surrounding mental health in the first responder community. I'm so proud and thankful to be part of the R3 team." Chief Noakes brings unmatched perspective to his new role. The son of a firefighter and 25 years of his own service with the FWPD, he has a unique understanding of pressures faced by first responders. During his tenure as Chief, he led several wellness-focused initiatives, including the launch of the department's Wellness Unit and the implementation of the Checkpoint system—a tool designed to monitor and support officer wellness. Noakes was instrumental in launching the inaugural R3 program with both FWPD and FWFD, the first partnership of its kind to recognize the urgency of addressing moral injury. "Chief Noakes represents the heart of what AWA stands for—service, integrity, and action. His firsthand experience and deep commitment to first responder wellness make him an extraordinary addition to our team," said AWA Executive Director Anna Heil. "He's not just joining an organization; he's joining a movement to change how we care for those who serve. We are incredibly grateful to have his leadership as we expand the reach and impact of R3." Noakes' professional credentials include: Master's Degree in Criminal Justice and Criminology from Texas Christian University (TCU) Bachelor's Degree in Criminal Justice Administration from Tarleton State University Associate's Degree from Weatherford College Graduate of TCU's inaugural Leadership, Executive and Administrative Development (LEAD) Program, where he now serves as a cofounder and instructor Graduate of the Southern Police Institute's 137th Administrative Officers Course, a nationally recognized law enforcement leadership program During the 89th Legislative Session, the Texas House and Senate presented official Resolutions establishing the first ever Moral Injury Awareness Day in Texas. The bipartisan effort underscores the state's commitment to raising awareness of the psychological and emotional toll faced by military members, veterans, first responders, frontline professionals and their families. Moral injury, a condition distinct from PTSD, and often considered its precursor, occurs when individuals witness, participate in, or fail to prevent actions that violate their moral values, leading to guilt, shame and moral distress. About R3 – Respond, Restore, Resolve Launched in Fort Worth and powered by the American Warrior Association (AWA), R3 is a pioneering initiative that equips first responders with the tools, support and resources needed to proactively address moral injury and improve mental, emotional, and spiritual well-being. The program enhances resilience, reduces absenteeism, and builds healthier departments—ultimately improving service to the community. R3 programming has been adopted by the Fort Worth and Dallas Fire and Police Departments, as well as DFW International Airport, with growing interest from multiple agencies across the state. Earlier this year, the Texas Tactical Police Officers Association (TTPOA) became an R3 Partner. The TTPOA membership base is approximately 5,500 individuals working within 2,300 organizations. About the American Warrior Association The American Warrior Association (AWA) is a Texas-based 501(c)(3) nonprofit organization dedicated to supporting our nation's military, veterans, first responders, and their families in mind, body, and soul. As the national steward of the R3 initiative, AWA continues to lead the charge in addressing the long-term wellness of America's frontline professionals. For more information about the R3 initiative, visit: View source version on Contacts Susan K. Medina, 817.707.1306 orBrooke Goggans, 617.680.1048;The Collaborative Sign in to access your portfolio


Business Wire
6 days ago
- Business Wire
Retired Fort Worth Police Chief Neil Noakes Joins The American Warrior Association as Chief of Strategic Advancement, Marks A New Chapter for Moral Injury Advocacy and First Responder Wellness
FORT WORTH, Texas--(BUSINESS WIRE)--Just weeks after Texas lawmakers stood alongside The American Warrior Association (AWA) in support of their program R3: Respond, Restore, Resolve – and first responders – to officially proclaim May 14, 2025, as Moral Injury Awareness Day, retired Fort Worth Police Department (FWPD) Chief Neil Noakes has joined the AWA as its Chief of Strategic Advancement, bringing decades of frontline experience and nationally respected leadership in public safety and officer wellness to advance the R3 program. 'I know the toll this work can take on first responders and their families. When I retired from the FWPD, I hoped to continue serving the community and the profession that's given so much to me. I'm grateful the AWA is the next step,' commented Noakes. Share 'I know the toll this work can take on first responders and their families. When I retired from the FWPD, I hoped to continue serving the community and the profession that's given so much to me. I'm grateful the AWA is the next step,' commented Noakes. 'The R3 program is providing critically important awareness of first responder wellness and the effects of moral injury, while simultaneously breaking the stigma surrounding mental health in the first responder community. I'm so proud and thankful to be part of the R3 team.' Chief Noakes brings unmatched perspective to his new role. The son of a firefighter and 25 years of his own service with the FWPD, he has a unique understanding of pressures faced by first responders. During his tenure as Chief, he led several wellness-focused initiatives, including the launch of the department's Wellness Unit and the implementation of the Checkpoint system—a tool designed to monitor and support officer wellness. Noakes was instrumental in launching the inaugural R3 program with both FWPD and FWFD, the first partnership of its kind to recognize the urgency of addressing moral injury. 'Chief Noakes represents the heart of what AWA stands for—service, integrity, and action. His firsthand experience and deep commitment to first responder wellness make him an extraordinary addition to our team,' said AWA Executive Director Anna Heil. 'He's not just joining an organization; he's joining a movement to change how we care for those who serve. We are incredibly grateful to have his leadership as we expand the reach and impact of R3.' Noakes' professional credentials include: Master's Degree in Criminal Justice and Criminology from Texas Christian University (TCU) Bachelor's Degree in Criminal Justice Administration from Tarleton State University Associate's Degree from Weatherford College Graduate of TCU's inaugural Leadership, Executive and Administrative Development (LEAD) Program, where he now serves as a cofounder and instructor Graduate of the Southern Police Institute's 137th Administrative Officers Course, a nationally recognized law enforcement leadership program During the 89 th Legislative Session, the Texas House and Senate presented official Resolutions establishing the first ever Moral Injury Awareness Day in Texas. The bipartisan effort underscores the state's commitment to raising awareness of the psychological and emotional toll faced by military members, veterans, first responders, frontline professionals and their families. Moral injury, a condition distinct from PTSD, and often considered its precursor, occurs when individuals witness, participate in, or fail to prevent actions that violate their moral values, leading to guilt, shame and moral distress. About R3 – Respond, Restore, Resolve Launched in Fort Worth and powered by the American Warrior Association (AWA), R3 is a pioneering initiative that equips first responders with the tools, support and resources needed to proactively address moral injury and improve mental, emotional, and spiritual well-being. The program enhances resilience, reduces absenteeism, and builds healthier departments—ultimately improving service to the community. R3 programming has been adopted by the Fort Worth and Dallas Fire and Police Departments, as well as DFW International Airport, with growing interest from multiple agencies across the state. Earlier this year, the Texas Tactical Police Officers Association (TTPOA) became an R3 Partner. The TTPOA membership base is approximately 5,500 individuals working within 2,300 organizations. About the American Warrior Association The American Warrior Association (AWA) is a Texas-based 501(c)(3) nonprofit organization dedicated to supporting our nation's military, veterans, first responders, and their families in mind, body, and soul. As the national steward of the R3 initiative, AWA continues to lead the charge in addressing the long-term wellness of America's frontline professionals. For more information about the R3 initiative, visit:
Yahoo
04-06-2025
- Yahoo
NodThera Charts Obesity Future with First Patients Dosed in Phase 2 RESOLVE-1 Trial of Oral NLRP3 Inflammasome Inhibitor NT-0796
NodThera Charts Obesity Future with First Patients Dosed in Phase 2 RESOLVE-1 Trial of Oral NLRP3 Inflammasome Inhibitor NT-0796Philadelphia, PA, June 4, 2025 - NodThera, a leading clinical-stage biotech delivering a paradigm shift in the treatment of chronic inflammatory diseases through selective modulation of the NLRP3 inflammasome, today announces that the first patients have been dosed in its Phase 2 RESOLVE-1 (RESolution Of infLammation to treat obesity and cardioVascular disEase) clinical trial investigating the potential of its lead candidate, oral NLRP3 inflammasome inhibitor NT-0796, in patients with obesity. NodThera's pioneering approach to obesity treatment is built on the growing understanding of the impact of chronic inflammation on the body and its fundamental role in the complex cycle of weight regulation which balances calorie intake, energy expenditure and satiety. While current drugs have made significant achievements in the management of obesity, their mechanisms primarily suppress the desire to eat (calorie restriction) or they promote a feeling of fullness, ultimately reducing food intake. NodThera's approach goes beyond the reduction of food intake by resetting the body's weight regulatory system and correcting the underlying imbalance, to return the body to its natural metabolic state. Daniel Swisher, Chief Executive Officer of NodThera, commented: 'With its novel molecular mechanism, the convenience of oral dosing without titration, and a well-tolerated safety profile, this fully brain-penetrant NLRP3 inflammasome inhibitor is projected to have a transformative impact on obesity by bringing the body back to balance. I am delighted that, following our recently closed $50 million Series D financing, we have accelerated our lead program into this robust Phase 2 trial, building on an impressive preclinical and clinical data set. This will support the progression of NT-0796 as an enhanced treatment for weight management, to enable patients to achieve sustained and healthy weight loss.' RESOLVE-1 is a randomized, double-blind, placebo-controlled Phase 2 trial that will evaluate the efficacy and safety of NT-0796 in patients with obesity, with or without type 2 diabetes, over 24 weeks. 160 patients are expected to be randomized into three treatment groups, receiving twice daily oral NT-0796, once daily oral NT-0796 or placebo. The trial's primary endpoint is the change in body weight in participants from baseline to week 24. Secondary endpoints include the impact of NT-0796 on body composition, metabolic biomarkers, and HbA1c levels in participants with type 2 diabetes. Headline data from the study are anticipated in Q2 2026. Returning the body to its natural metabolic balance – homeostasis Earlier preclinical and clinical work undertaken by the Company has demonstrated that NLRP3, an intracellular sensor and master switch that modulates inflammation, plays a key role in controlling obesity and obesity-associated inflammation. The fully brain-penetrant NT-0796 reduces inflammation in the brain, as well as throughout the body, to restore multiple dysregulated cardiometabolic pathways. The inhibition of NLRP3 results in the loss of fat mass, while preserving lean muscle mass, and restores the body's natural metabolic balance (homeostasis), enabling sustainable, enhanced and healthy weight loss. Positive clinical data announced by the Company in June 2024, from a Phase 1b/2a cardiovascular risk study in patients with obesity, confirmed NT-0796's profound anti-inflammatory effect and supported its anti-obesity potential. This followed the publication of preclinical data in the Journal of Pharmacology and Experimental Therapeutics, demonstrating the potential of NT-0796 to reverse diet-induced obesity and inflammation in an animal model of the disease, matching weight loss driven by the GLP-1 receptor agonist, semaglutide. Most recently, data published in the journal Obesity showed the enhanced weight loss effect of NT-0796 when combined with semaglutide in a preclinical obesity model. The potential of NT-0796 to improve the efficacy and tolerability of existing GLP-1RA obesity therapies will be further investigated in NodThera's upcoming Phase 2 combination trial, RESOLVE-2, expected to commence in H2 2025. Alan Watt, President and Chief Scientific Officer of NodThera, added: 'Through central NLRP3 inhibition and the correction of multiple dysregulated pathways in the brain and throughout the body, NT-0796 has the potential to deliver robust weight loss and broad cardiometabolic benefits that go beyond those seen with current therapies. NodThera's treatment approach, restoring the body's natural metabolic balance, would be game-changing.' For more information about NodThera please contact: NodTheraTel: +44 (0) 1223 608130Email: info@ ICR Healthcare Amber Fennell, David Daley Tel: +44 (0)20 3709 5700Email: nodthera@ About NodTheraNodThera is a leading clinical-stage biotech developing brain-penetrant NLRP3 inflammasome inhibitors to treat chronic inflammatory diseases. Led by an experienced management team, NodThera is combining a deep understanding of NLRP3 inhibition, pharmaceutical neuroscience expertise and precision chemistry. Its two lead clinical candidates are oral, small molecule NLRP3 inflammasome inhibitors, which have demonstrated differentiated, potentially best-in-class clinical profiles with significant anti-inflammatory effects and high brain penetration, offering distinct opportunities to treat multiple indications. The Company is backed by top-tier investors including 5AM Ventures, Blue Owl Capital, Epidarex Capital, F-Prime Capital, Novo Holdings, Sanofi Ventures and Sofinnova Partners. NodThera is headquartered in Philadelphia, Pennsylvania, with additional operations in Cambridge, UK. Learn more at or follow the Company on in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data